US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership

U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda ...
WDAF-TV

Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...
C&EN

How AI is taking over every step of drug discovery

Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...
FierceBiotech

Japan biotech inks research pact in effort to develop new RNA meds

Japan biotech xFOREST Therapeutics is teaming up with a drug discovery solutions provider in a research pact aiming to develop new RNA structure-targeted small molecule therapeutics, including mRNA ...
Observer

Daphne Koller Wants to Fix Drug Discovery With A.I.—and Real Data

Daphne Koller, founder and CEO of Insitro, has secured major partnerships with pharmaceutical giants like Eli Lilly and Bristol Myers Squibb to advance A.I.-powered drug discovery. Courtesy of Insitro ...

Exploring the power of plants to make drugs out of sunlight

Plants are consummate chemists, using the sun's energy and carbon dioxide from the air, to conjure a dazzling array of ...
Zacks Investment Research on MSNOpinion

5 Small Drug Stocks to Buy as the Industry Shows Some Recovery

The drug and biotech sector bounced back this month after struggling this year due to tariff and pricing fears and broader ...